Direct in vivo gene transfer into the coronary and peripheral vasculatures of the intact dog

Chang S. Lim, Gregory D. Chapman, Roger S. Gammon, Joseph B. Muhlestein, Robert P. Bauman, Richard S. Stack, Judith L. Swain

Research output: Contribution to journalArticle

122 Citations (Scopus)

Abstract

Gene therapy approaches have been suggested for the treatment of cardiovascular disease. Recently, direct transfer of the gene encoding β-galactosidase into peripheral arteries of the pig has been demonstrated. To determine whether this approach is applicable to other arterial beds and to other species, we first evaluated the use of β-galactosidase as a marker protein in the canine model. We demonstrate that variable but substantial endogenous β-galactosidase-like activity is induced by manipulation of canine peripheral arteries, which precludes the use of this marker protein in evaluating the efficiency of gene transfer in this model. A marker gene encoding firefly luciferase was then evaluated, and background luciferase activity was found to be low in the dog even after arterial manipulation. Using the luciferase gene, we then demonstrated lipid-mediated gene transfer directly into both coronary and peripheral arteries of the intact dog. These results indicate the feasibility of in vivo gene transfer into coronary arteries and demonstrate the use of the luciferase marker protein in quantifying recombinant protein expression following gene transfer in canine models. This simple and effective method for direct in vivo gene transfer into coronary and peripheral arteries may be applicable to the localized production of therapeutically important proteins for the treatment of cardiovascular diseases.

Original languageEnglish
Pages (from-to)2007-2011
Number of pages5
JournalCirculation
Volume83
Issue number6
StatePublished - Jun 1 1991
Externally publishedYes

Fingerprint

Dogs
Galactosidases
Genes
Luciferases
Canidae
Coronary Vessels
Proteins
Cardiovascular Diseases
Arteries
Firefly Luciferases
Recombinant Proteins
Genetic Therapy
Swine
Lipids
Gene Expression
Therapeutics

Keywords

  • Genetics
  • Lipofection
  • Luciferase

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Lim, C. S., Chapman, G. D., Gammon, R. S., Muhlestein, J. B., Bauman, R. P., Stack, R. S., & Swain, J. L. (1991). Direct in vivo gene transfer into the coronary and peripheral vasculatures of the intact dog. Circulation, 83(6), 2007-2011.

Direct in vivo gene transfer into the coronary and peripheral vasculatures of the intact dog. / Lim, Chang S.; Chapman, Gregory D.; Gammon, Roger S.; Muhlestein, Joseph B.; Bauman, Robert P.; Stack, Richard S.; Swain, Judith L.

In: Circulation, Vol. 83, No. 6, 01.06.1991, p. 2007-2011.

Research output: Contribution to journalArticle

Lim, CS, Chapman, GD, Gammon, RS, Muhlestein, JB, Bauman, RP, Stack, RS & Swain, JL 1991, 'Direct in vivo gene transfer into the coronary and peripheral vasculatures of the intact dog', Circulation, vol. 83, no. 6, pp. 2007-2011.
Lim CS, Chapman GD, Gammon RS, Muhlestein JB, Bauman RP, Stack RS et al. Direct in vivo gene transfer into the coronary and peripheral vasculatures of the intact dog. Circulation. 1991 Jun 1;83(6):2007-2011.
Lim, Chang S. ; Chapman, Gregory D. ; Gammon, Roger S. ; Muhlestein, Joseph B. ; Bauman, Robert P. ; Stack, Richard S. ; Swain, Judith L. / Direct in vivo gene transfer into the coronary and peripheral vasculatures of the intact dog. In: Circulation. 1991 ; Vol. 83, No. 6. pp. 2007-2011.
@article{98de1360fe1440f5b1d91b408559278f,
title = "Direct in vivo gene transfer into the coronary and peripheral vasculatures of the intact dog",
abstract = "Gene therapy approaches have been suggested for the treatment of cardiovascular disease. Recently, direct transfer of the gene encoding β-galactosidase into peripheral arteries of the pig has been demonstrated. To determine whether this approach is applicable to other arterial beds and to other species, we first evaluated the use of β-galactosidase as a marker protein in the canine model. We demonstrate that variable but substantial endogenous β-galactosidase-like activity is induced by manipulation of canine peripheral arteries, which precludes the use of this marker protein in evaluating the efficiency of gene transfer in this model. A marker gene encoding firefly luciferase was then evaluated, and background luciferase activity was found to be low in the dog even after arterial manipulation. Using the luciferase gene, we then demonstrated lipid-mediated gene transfer directly into both coronary and peripheral arteries of the intact dog. These results indicate the feasibility of in vivo gene transfer into coronary arteries and demonstrate the use of the luciferase marker protein in quantifying recombinant protein expression following gene transfer in canine models. This simple and effective method for direct in vivo gene transfer into coronary and peripheral arteries may be applicable to the localized production of therapeutically important proteins for the treatment of cardiovascular diseases.",
keywords = "Genetics, Lipofection, Luciferase",
author = "Lim, {Chang S.} and Chapman, {Gregory D.} and Gammon, {Roger S.} and Muhlestein, {Joseph B.} and Bauman, {Robert P.} and Stack, {Richard S.} and Swain, {Judith L.}",
year = "1991",
month = "6",
day = "1",
language = "English",
volume = "83",
pages = "2007--2011",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Direct in vivo gene transfer into the coronary and peripheral vasculatures of the intact dog

AU - Lim, Chang S.

AU - Chapman, Gregory D.

AU - Gammon, Roger S.

AU - Muhlestein, Joseph B.

AU - Bauman, Robert P.

AU - Stack, Richard S.

AU - Swain, Judith L.

PY - 1991/6/1

Y1 - 1991/6/1

N2 - Gene therapy approaches have been suggested for the treatment of cardiovascular disease. Recently, direct transfer of the gene encoding β-galactosidase into peripheral arteries of the pig has been demonstrated. To determine whether this approach is applicable to other arterial beds and to other species, we first evaluated the use of β-galactosidase as a marker protein in the canine model. We demonstrate that variable but substantial endogenous β-galactosidase-like activity is induced by manipulation of canine peripheral arteries, which precludes the use of this marker protein in evaluating the efficiency of gene transfer in this model. A marker gene encoding firefly luciferase was then evaluated, and background luciferase activity was found to be low in the dog even after arterial manipulation. Using the luciferase gene, we then demonstrated lipid-mediated gene transfer directly into both coronary and peripheral arteries of the intact dog. These results indicate the feasibility of in vivo gene transfer into coronary arteries and demonstrate the use of the luciferase marker protein in quantifying recombinant protein expression following gene transfer in canine models. This simple and effective method for direct in vivo gene transfer into coronary and peripheral arteries may be applicable to the localized production of therapeutically important proteins for the treatment of cardiovascular diseases.

AB - Gene therapy approaches have been suggested for the treatment of cardiovascular disease. Recently, direct transfer of the gene encoding β-galactosidase into peripheral arteries of the pig has been demonstrated. To determine whether this approach is applicable to other arterial beds and to other species, we first evaluated the use of β-galactosidase as a marker protein in the canine model. We demonstrate that variable but substantial endogenous β-galactosidase-like activity is induced by manipulation of canine peripheral arteries, which precludes the use of this marker protein in evaluating the efficiency of gene transfer in this model. A marker gene encoding firefly luciferase was then evaluated, and background luciferase activity was found to be low in the dog even after arterial manipulation. Using the luciferase gene, we then demonstrated lipid-mediated gene transfer directly into both coronary and peripheral arteries of the intact dog. These results indicate the feasibility of in vivo gene transfer into coronary arteries and demonstrate the use of the luciferase marker protein in quantifying recombinant protein expression following gene transfer in canine models. This simple and effective method for direct in vivo gene transfer into coronary and peripheral arteries may be applicable to the localized production of therapeutically important proteins for the treatment of cardiovascular diseases.

KW - Genetics

KW - Lipofection

KW - Luciferase

UR - http://www.scopus.com/inward/record.url?scp=0025833321&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025833321&partnerID=8YFLogxK

M3 - Article

VL - 83

SP - 2007

EP - 2011

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 6

ER -